About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.11304338091762.2894
Domestic EquitiesCipla Ltd.9.22654742991580.6370
Domestic EquitiesMankind Pharma Ltd.7.01442200753441.4270
Domestic EquitiesBiocon Ltd.6.076910596543382.4292
Domestic EquitiesDr. Reddy's Laboratories Ltd.5.97302995363375.8881
Domestic EquitiesDivi's Laboratories Ltd.5.9052624887371.6203
Domestic EquitiesLupin Ltd.4.08671111456257.1798
Domestic EquitiesAlkem Laboratories Ltd.3.5248418609221.8209
Domestic EquitiesSyngene International Ltd.3.51745677160221.3525
Domestic EquitiesAurobindo Pharma Ltd.3.30091592551207.7324
Domestic EquitiesCohance Lifesciences Ltd.3.17576629758199.8541
Domestic EquitiesMedplus Health Services Ltd2.72982045332171.7874
Domestic EquitiesAlivus Life Sciences Ltd.2.43711576713153.3669
Domestic EquitiesZydus Lifesciences Ltd.2.02931465859127.7056
Domestic EquitiesEntero Healthcare Solutions1.9001958284119.5747
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.8984578725119.4720
Domestic EquitiesAkums Drugs and Pharmaceuticals Ltd.1.82722467084114.9908
Domestic EquitiesThyrocare Technologies Ltd.1.73553124484109.2163
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.62441541322102.2282
Domestic EquitiesGland Pharma Ltd.1.549557490897.5101
Domestic EquitiesPfizer Ltd.1.353418043085.1720
Domestic EquitiesMetropolis Healthcare Ltd.1.2627183100879.4657
Domestic EquitiesMedi Assist Healthcare Services Ltd1.1354240773971.4497
Domestic EquitiesBlue Jet Healthcare Ltd.1.1266216642270.8962
Domestic EquitiesAnthem Biosciences Ltd1.0635101981466.9253
Domestic EquitiesFine Organic Industries Ltd.1.060616866666.7428
Domestic EquitiesWindlas Biotech Ltd.1.004185765163.1874
Domestic EquitiesSanofi Consumer Healthcare India Ltd0.983214396061.8769
Domestic EquitiesHikal Ltd.0.9349400009458.8334
Domestic EquitiesAarti Drugs Ltd.0.9324183506258.6761
Domestic EquitiesGlenmark Pharmaceuticals Ltd.0.787623250449.5629
Domestic EquitiesSenores Pharmaceuticals Ltd0.763763267048.0576
Domestic EquitiesShilpa Medicare Ltd.0.7537135953147.4340
Domestic EquitiesAstrazeneca Pharma India Ltd.0.71925828245.2589
Domestic EquitiesFDC Ltd.0.6179121095338.8837
Domestic EquitiesLaxmi Dental Ltd.0.5552220785934.9394
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.4758260631529.9440
Domestic EquitiesNephrocare Health Services Ltd0.442954991727.8725
Total 97.6184 6143.2612
Cash & Cash Equivalents and Net AssetsTREPS2.6770 168.4663
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.0064 0.4052
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.3336 -20.9936
Total 2.3498 147.8779
Treasury Bills91 Days Treasury Bills0.03172000001.9977
Total 0.0317 1.9977
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.